Could a pill replace your CPAP machine for sleep apnea?
NCT ID NCT06295562
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed phase 4 trial tested three different drug combinations to treat obstructive sleep apnea in 45 adults. The drugs aim to improve how the airway stays open during sleep. Participants took either a drug combo or a placebo before bed, and their sleep was monitored overnight. The main goal was to see if the drugs reduced the number of breathing pauses per hour.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- atomoxetine, oxybutynin, venlafaxine, trazodone
- What this could lead to
- If successful, these drug combinations could offer a new medication option for people with obstructive sleep apnea who cannot use CPAP machines.
- What could go wrong
- This is a small, early-phase trial with only 45 participants. The drugs may not work for everyone and could cause side effects like dry mouth or dizziness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
45 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * apnea-hypopnea index ≥ 15 hr-¹ Exclusion Criteria: * the presence of pulmonary, cardiac, neurologic, or other active severe medical or psychiatric diseases * current use of continuous positive airway pressure therapy * use of drugs that might interact with the investigational medication or known to affect sleep during the trial or 1 month before the study * known allergy to the investigational medication * current smoking * heavy alcohol drinking (male \> 14 drinks and women \>7 drinks per week) * pregnant or lactating * periodic limb movement index \> 15hr-1 * the presence of sleep-related hypoventilation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea of adult are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China Medical University Hospital
Taichung, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain blood flow may hold key to sleep apnea breathing stability
- Smart watch boosts CPAP use in sleep apnea patients
- Melatonin may fix sleep and blood pressure in sleep apnea patients
- Can a sleep machine protect pregnant women from dangerous blood pressure?
- Sleep apnea patients may get heart help from statins
- Sleep apnea may damage fat cells, raising heart risks